Serotonin syndrome during clomipramine monotherapy: Comparison of two diagnostic criteria

Psychiatry and Clinical Neurosciences

Volumn 51, Issue 1, 1997, Pages 43-46

  Kudo, Kiyomi ^a   Sasaki, Ichiro ^a   Tsuchiyama, Konosuke ^a   Akiyoshi, Jotaro ^a   Nagayama, Haruo ^a   Fujii, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

clomipramine; diagnostic criteria; serotonin syndrome

Indexed keywords

CLOMIPRAMINE;

ADULT; ARTICLE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOPHARMACOTHERAPY; SEROTONIN SYNDROME; SYMPTOMATOLOGY;

EID: 0031048028     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1997.tb02365.x     Document Type: Article

References (11)

1. Ayd FJ, Ayd FJ Jr. Lexicon of Psychiatry, Neurology, and the Neurosciences. William & Wilkins, Baltimore, 1995.
2. Brown TM, Skop BP, Mareth TR. Pathophysiology and management of the serotonin syndrome. Ann. Pharmacother. 1996; 30: 527-533.
3. Sternbach H. The serotonin syndrome. Am. J. Psychiatry 1991; 148: 705-713.
4. Dursun SM, Burke JG, Reveley MA. Toxic serotonin syndrome or extrapyramidal side-effects? Br. J. Psychiatry 1995; 166: 401-402.
5. Sasaki I, Akiyoshi J, Tsuchiyama K. The serotonin syndrome during clomipramine monotherapy. Clinical Psychiatry. 1996; 38: 727-731 (in Japanese).
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd edn) APA, Washington DC, 1981.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (3rd edn., rev.). APA, Washington DC, 1987.
8. Gerson SC, Baldessarini RJ. Motor effects of serotonin in the central nervous system. Life Sci. 1980; 27: 1435-1451.
9. Lejoyeux M, Ades J, Rouillon F. Serotonin Syndrome: Incidence, symptoms and treatment. CNS Drugs 1994; 2: 132-143.
10. Sporer KA. The serotonin syndrome/Implicated Drugs, Pathophysiology and Management. Drug Safety 1995; 13: 94-104.
11. Kline SS, Mauro LS, Scala-Barnett DM. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin. Pharm. 1989; 8: 510-514.